Showing 1 - 10 of 63
Persistent link: https://www.econbiz.de/10011999658
Persistent link: https://www.econbiz.de/10011563708
Persistent link: https://www.econbiz.de/10011456704
Persistent link: https://www.econbiz.de/10014566158
"A disproportionate impact on health system performance Private health insurance makes a small contribution to spending on health in most countries around the world, but its effect on health system performance can be surprisingly large owing to market failures and weaknesses in public policy....
Persistent link: https://www.econbiz.de/10014380116
1. Introduction / Michael Anderson, Anuja Chatterjee, Charles Clift, Elias Mossialos -- 2. The health and economic burden of antimicrobial resistance / Driss Ait Ouakrim, Alessandro Cassini, Michele Cecchini, Diamantis Plachouras --3. Tackling antimicrobial resistance in the community / Sarah...
Persistent link: https://www.econbiz.de/10012424662
Antimicrobial resistance (AMR) is a biological mechanism whereby a microorganism evolves over time to develop the ability to become resistant to antimicrobial therapies such as antibiotics. The drivers of and potential solutions to AMR are complex, often spanning multiple sectors. The...
Persistent link: https://www.econbiz.de/10012512188
A generally accepted view is that it is more efficient and ethical if global pharmaceutical prices vary according to countries? relative income. To understand manufacturers? pricing strategies, we compared average pharmaceutical prices in fourteen middle-income countries to those in three...
Persistent link: https://www.econbiz.de/10009481241
Persistent link: https://www.econbiz.de/10012810122
Persistent link: https://www.econbiz.de/10005509048